We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Biosensor Enables Early Diagnosis of Cervical Cancer

By LabMedica International staff writers
Posted on 21 Dec 2023
Print article
Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)
Image: The electrochemical sensor detects HPV-16 and HPV-18 with high specificity (Photo courtesy of 123RF)

Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community. These nanosheets are formed through the stacking of S–Mo–S layers that are held together by Van der Waals forces. MoS2's distinctive structural, optical, thermal, and electrochemical attributes have paved the way for research in diverse domains, including biomolecule sensing, optoelectronics, energy storage, and more. Historically, carbon nanostructures have been used as an immobilization platform for DNA. To replace carbon with MoS2 as an effective electrochemical DNA sensor, the electrical conductivity of MoS2 must be improved significantly.

To tackle this challenge, researchers at Chung-Ang University (Seoul, South Korea) have devised an electrochemical DNA biosensor using a composite of graphitic nano-onions and MoS2 nanosheets. This biosensor shows promise in detecting human papillomavirus (HPV) types 16 and 18, offering the potential for early cervical cancer diagnosis. The team measured the biosensor's sensitivity to these HPV types using the differential pulse voltammetry (DPV) technique in conjunction with methylene blue (MB) as a redox indicator. They observed that the nano-onion/MoS2 nanosheet composite electrode demonstrated higher current peaks than its MoS2-only counterpart, suggesting enhanced conductive electron transfer facilitated by the nano-onions.

This enhancement led to the effective and specific detection of target DNAs from HPV-16 and HPV-18 Siha and Hela cancer cell lines. As a result, MoS2 nanosheets with improved electrical conductivity, when combined with nano-onions, have shown potential as a robust platform for creating electrochemical biosensors that can efficiently diagnose various health conditions, including cervical cancer. Moreover, the integration of nano-onions or nanodiamonds with various organic biomaterials could lead to advancements in chemical functionality, electron transfer conductivity, light absorption, and more. These developments hold promise for groundbreaking applications in disease sensing, targeted drug delivery, and biomedical imaging and diagnostics.

Related Links:
Chung-Ang University 

New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Plasmodium Parasites Test
Plasmodium Genotyping Real Time PCR Kit
New
UHF RFID Tag & Inlay
AD-164 U9

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The researchers used state-of the-art equipment for isotope ratio mass spectrometry (Photo courtesy of The University of Melbourne)

New Blood Test to Detect Alzheimer’s Disease Before Clinical Symptoms Develop

Alzheimer’s disease (AD) is the most common form of dementia, accounting for 60-70% of cases worldwide, totaling over 33 million, according to the World Health Organization. As the global population ages,... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
Image: The ChatGPT-like AI model can diagnose cancer, guide treatment choice, predict survival across multiple cancer types (Photo courtesy of 123RF)

AI Tool Diagnoses Cancer, Guides Treatment and Predicts Survival Across Multiple Cancer Types

Current artificial intelligence (AI) models are typically specialized, designed for specific tasks like detecting cancer or predicting tumor genetics, and are limited to a few cancer types.... Read more

Industry

view channel
Image: Roche has expanded its digital pathology open environment with more than 20 AI algorithms (Photo courtesy of Roche)

Roche Expands Digital Pathology Open Environment with Integration of Advanced AI Algorithms from New Collaborators

Roche (Basel, Switzerland) has expanded its digital pathology open environment by integrating over 20 advanced artificial intelligence (AI) algorithms from eight new collaborators. These strategic collaborations... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.